Bone Biologics Corp (BBLGW) Net Equity Issued and Repurchased (2016 - 2024)
Bone Biologics (BBLGW) posted quarterly Net Equity Issued and Repurchased of -$226.0 for Q3 2024, down 64.96% quarter-over-quarter from -$137.0 in Q2 2024.
Bone Biologics Corp (BBLGW) Net Equity Issued and Repurchased (2016 - 2024) Analysis & Trends
Bone Biologics (BBLGW) has reported Net Equity Issued and Repurchased for 4 consecutive years, with -$226.0 the latest figure, recorded in Q3 2024.
- In Q3 2024, Net Equity Issued and Repurchased changed N/A year-over-year to -$226.0; the TTM figure through Dec 2025 stood at -$226.0 (down 100.02% YoY), while the FY2025 annual figure was $4.4 million, up 189.39% from the prior year.
- Net Equity Issued and Repurchased declined to -$226.0 in Q3 2024 per BBLGW's latest filing, from -$137.0 in the prior quarter.
- Across five years, Net Equity Issued and Repurchased topped out at $1.5 million in Q1 2024 and bottomed at -$226.0 in Q3 2024.
Powered by 
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2024 | -226.00 |
| Sep 30, 2024 | -226.00 |
| Jun 30, 2024 | -137.00 |
| Jun 30, 2024 | -137.00 |
| Mar 31, 2024 | 1.50 Mn |
| Mar 31, 2024 | 1.50 Mn |
| Dec 31, 2023 | 591,998.00 |
| Dec 31, 2023 | 591,998.00 |
| Sep 30, 2018 | 3.87 Mn |
| Sep 30, 2018 | 3.87 Mn |
| Jun 30, 2018 | 7,500.00 |
| Jun 30, 2018 | 7,500.00 |
| Mar 31, 2018 | 500,000.00 |
| Mar 31, 2018 | 500,000.00 |
| Mar 31, 2016 | 2.50 Mn |
| Mar 31, 2016 | 2.50 Mn |